Thymosin Alpha-1 Peptide CAS 62304-98-7 2mg 10 Vials Lyophilized Powder Research Grade USD 55
TDS 7525 Inquiries
2381089-83-2
Pharmaceutical Grade
99%
广州
Chunqiao
5mg 10mg
Yes
2026-11-29
peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.CertificatesBasic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Jastreboff et al. (2023) — Phase 2 Trial ; FDA Drugs@FDA
Disclaimer:Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Unit 1-B2141, 19B-F1, 81-1 Nonglinxia Road, Yuexiu District, Guangzhou, China
-
Payment Terms:
100% TT in advance
-
Year of Establishment:
2026
-
-
Inquiry History7525 Inquiries
Country Product Purchase Quantity Date Posted
Slovakia
Retatrutide
30 MG Nov 2, 2026
France
Retatrutide
5 MG Nov 2, 2026
United States
Retatrutide
10 MG Nov 2, 2026
South Africa
Retatrutide
32 MG Nov 2, 2026
United States
Retatrutide
2 MT Nov 2, 2026
United States
Retatrutide
1 KG Nov 2, 2026
United States
Retatrutide
10 MT Nov 2, 2026
United States
Retatrutide
4 MT Nov 2, 2026
United Kingdom
Retatrutide
1 KG Nov 1, 2026
United Kingdom
Retatrutide
10 MT Nov 1, 2026
United Kingdom
Retatrutide
300 MG Oct 31, 2026
Canada
Retatrutide
20 MG Oct 31, 2026
South Korea
Retatrutide
1 G Oct 31, 2026
South Africa
Retatrutide
5 MT Oct 31, 2026
United States
Retatrutide
100 MT Oct 31, 2026
Poland
Retatrutide
1 BOU Oct 30, 2026
United States
Retatrutide
10 PCS Oct 30, 2026
Paraguay
Retatrutide
1000 PCS Oct 30, 2026
United Kingdom
retatrutide
300 MG Oct 30, 2026
United States
Retatrutide
10 G Oct 30, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Adipotide Peptide Compound, Research Grade for Cell Assay Study
Cosmetics Grade / 99%
$60/UNIT FOB
-
-
-
-
NAD+ Molecular Coenzyme For Energy Metabolism Enzyme Activity In Vitro Investigation
Cosmetics Grade / 99%
$45/UNIT FOB
-
-
-
-
Glutathione-- high purity Glutathione- with best price
Pharmaceutical Grade / 99%
-
-
-
-
IGF1-dfs White Powder For Research Purpose Only Pharmaceutical Grade
Pharmaceutical Grade / 99%
$45-55/MT FOB
-
-
-
-
Pramlintide Amylin Analog Research Sample For Pancreatic Post Meal Regulation Mixture
Cosmetics Grade / 99%
$135/UNIT FOB
-
-
-
-
TB500 BT10
Pharmaceutical Grade / 99%
-
